Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised to reshape virtual screening in early stage drug discovery and enhance ...

We develop cutting-edge software and AI solutions for small molecule design, optimization and data analysis. Our mission is ...

Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...

Antibiotic resistance has emerged as one of the gravest global health challenges of the 21st century, undermining the effectiveness of available treatments ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ...

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development Virtual Event ...